Market closedNon-fractional
Absci/ABSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Absci
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Ticker
ABSI
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Vancouver, United States
Employees
155
Website
www.absci.com
Absci Metrics
BasicAdvanced
$495M
Market cap
-
P/E ratio
-$1.16
EPS
2.39
Beta
-
Dividend rate
Price and volume
Market cap
$495M
Beta
2.39
Financial strength
Current ratio
7.189
Quick ratio
6.39
Long term debt to equity
3.777
Total debt to equity
5.932
Interest coverage (TTM)
-107.16%
Management effectiveness
Return on assets (TTM)
-20.30%
Return on equity (TTM)
-44.20%
Valuation
Price to revenue (TTM)
77.006
Price to book
2.06
Price to tangible book (TTM)
2.57
Price to free cash flow (TTM)
-6.54
Growth
Revenue change (TTM)
-13.72%
Earnings per share change (TTM)
6.72%
3-year revenue growth (CAGR)
0.48%
3-year earnings per share growth (CAGR)
-27.02%
What the Analysts think about Absci
Analyst Ratings
Majority rating from 6 analysts.
Absci Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$800K
166.67%
Net income
-$22M
-6.81%
Profit margin
-2,737.50%
-65.05%
Absci Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.45
-$0.24
-$0.25
-$0.22
-
Expected
-$0.24
-$0.23
-$0.25
-$0.21
-$0.19
Surprise
84.43%
4.35%
3.25%
3.77%
-
Absci News
AllArticlesVideos
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
GlobeNewsWire·2 weeks ago
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewsWire·3 weeks ago
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Absci stock?
Absci (ABSI) has a market cap of $495M as of July 27, 2024.
What is the P/E ratio for Absci stock?
The price to earnings (P/E) ratio for Absci (ABSI) stock is 0 as of July 27, 2024.
Does Absci stock pay dividends?
No, Absci (ABSI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Absci dividend payment date?
Absci (ABSI) stock does not pay dividends to its shareholders.
What is the beta indicator for Absci?
Absci (ABSI) has a beta rating of 2.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Absci stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.